Hattersley Gary's Form 4 filing
Nuvation Bio Inc. (NUVB) · filed Nov 24, 2025
- Accession no.
- 0001521111-25-000006
- Filed
- Nov 24, 2025
- Trade date
- Nov 20, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.67M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hattersley GaryCIK 0001521111 | Officer (CHIEF SCIENTIFIC OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Class A Common Stock | MOption exerciseAcquired | +69,051 | $1.74 | +$120,148.74 | 69,051 | Direct | |
| Nov 20, 2025 | Class A Common Stock | SSaleDisposed | −69,051 | $7.23F1 | −$499,238.73 | 0 | Direct | |
| Nov 20, 2025 | Class A Common Stock | MOption exerciseAcquired | +300,000 | $1.94 | +$582,000 | 300,000 | Direct | |
| Nov 20, 2025 | Class A Common Stock | SSaleDisposed | −300,000 | $7.23F1 | −$2,169,000 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Class A Common Stock | MOption exerciseDisposed | −69,051 | $0.00 | $0 | 229,884 | Direct | |
| Nov 20, 2025 | Class A Common Stock | MOption exerciseDisposed | −300,000 | $0.00 | $0 | 200,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.